Last reviewed · How we verify
CYD-TDV Dengue Vaccine — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
CYD-TDV Dengue Vaccine (CYD-TDV Dengue Vaccine) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CYD-TDV Dengue Vaccine TARGET | CYD-TDV Dengue Vaccine | Sanofi Pasteur, a Sanofi Company | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CYD-TDV Dengue Vaccine CI watch — RSS
- CYD-TDV Dengue Vaccine CI watch — Atom
- CYD-TDV Dengue Vaccine CI watch — JSON
- CYD-TDV Dengue Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). CYD-TDV Dengue Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/cyd-tdv-dengue-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab